Exploratory Clinical Trials for Small Business Grant Program
Page 2

That said, the NINDS seeks to provide support to small businesses in their quest to develop emerging technologies that will potentially be beneficial to the objective in focus.

The examples of the kinds of studies that will be supported under this program are those that aim to:

a) Evaluate and optimize the dose, formulation, safety, tolerability/pharmacokinetics of a certain intervention or diagnostic test in healthy volunteers or the target population

b) Prospective clinical validation of a diagnostic

c) Asses whether or not an intervention produces sufficient evidence of short-term activity in a human “proof of concept” trial

d) Determine the best of two or more potential interventions or dosing regimens that will be evaluated in a subsequent trial, based on tolerability, biological activity, or preliminary clinical efficacy.

The NIH and NINDS are set to administer a funding amount of $750,000 per grant awardee to support the execution of this program.

The institutions and organizations who will be considered eligible to submit an application under this program are those Small Business Concerns that meet the following criteria:

a) SBCs that are mainly organized for profit and is located and operating in the United States, and makes a substantial contribution to the United States economy through payment of taxes or use of American products, materials or labor;

b) SBCs that are in the legal form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust or cooperative;

c) SBCs that does not have more than 500 employees

d) SBSs that are at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States.

Exploratory Clinical Trials for Small Business Grant Program
  Back to Page 1

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Eradication of HIV from CNS Reservoirs: Implications for Therapeutics Grant Program
The National Institutes of Health has collaborated with The National Institute of Mental Health (NIMH), The National Institute of Neurological Disorders and Stroke (NINDS), and The National Institute of Allergy and Infectious Disease (NIAID) in an attempt to establish the Eradication of HIV from CNS Reservoirs: Implications for Therapeutics Grant Program.

---

Early-Stage Innovative Technology Development for Cancer Research Program
The National Institutes of Health has collaborated with the National Cancer Institute(NCI) in order to establish Early-Stage Innovative Technology Development for Cancer Research Program, wherein both agencies intend to solicit grant applications expressing intents to conduct funded exploratory research projects that concentrate on the inception and development unique, innovative technological advances that could potentially be utilized in the study of cancer.

---

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

HRSA: Reducing Loss to Follow-up after Failure to Pass Newborn Hearing Screening
Reducing to Loss of Follow-up after Failure to Pass Newborn Hearing Screening program enables eligible health care institutions to solicit funds by establishing project proposals that would greatly improve the number of infants receiving appropriate and timely follow-ups through the utilization of patient-centered interventions.

---